As readers of this blog are aware, Byetta (also called exenatide), the first approved medication in the class of diabetes drugs called "GLP-1 mimetics" or "GLP-1 receptor agonists", has been associated with a potentially fatal complication called pancreatitis. No one has been quite sure whether the pancreatitis complication is due to use of the drug, or coincidental -- as PWD have an increased incidence of pancreatitis. The FDA, however, has insisted on the manufacturer strengthening Byetta's...
What Is A Glp-1 Agonist?
Featured Health Expert
More information on "What Is A Glp-1 Agonist?"
From Our Experts
EXPERT
Oral GLP-1
By David Mendosa, Health Expert
A pill form of GLP-1 may be coming. That’s the gist of a late breaking abstract at the American Diabetes Association’s annual... Read more »
EXPERT
Prostate Cancer Treatment Options: Medical Castration: Antagonist vs...
By Jay Motola, Health Expert
Medical therapy to induce a castration is generally intended for use in patients who have advanced disease not curable by surgery,... Read more »
EXPERT
Medical Oncologist's Response to Luteinizing Hormone-Releasing...
By Alvaro Pereira-Rico, MD, Health Expert
Breast Cancer News Editor's Note: Science and health news outlet EurekAlert! published yesterday an interesting summary of a Lancet study ... Read more »
EXPERT
What Do You Do if You are Forced to Come Off of Your Opioid Pain...
By Will Rowe, Health Expert
Opioid medications have a natural property that causes physical dependence. Other medications used to treat high blood pressure,... Read more »
EXPERT
Prescription Painkiller Addiction – Your Questions?
By Karen Lee Richards, Health Expert
When it comes to taking opioid medications for pain, there is often a fear of becoming addicted. How can you tell if you are in control... Read more »
From Our Sources
Nausea drug shows promise against opioid addiction
A drug currently used to treat nausea can prevent symptoms of withdrawal from illegal and prescription opioid drugs such as heroin, morphine and... Read more »
Clinical trial: New med for OIC
This is a study is to evaluate the safety and effectiveness of a new medication (MOA-728) for opioid-induced constipation. This national study is in... Read more »
Painkillers Darvon and Darvocet Pulled from Market
Drugmaker Xanodyne Pharmaceuticals has voluntarily pulled the opioid-based painkillers Darvon and Darvocet from the U.S. market after the drugs were... Read more »
Clinical trial: Safety and effectiveness of OraVescent fetanyl...
This is a study to determine the safety and effectiveness of OraVescent fetanyl for patients who are opioid-tolerant and who have chronic,... Read more »
Clinical trial: New drug for opioid-induced constipation
This is a study to evaluate a new drug (MOA-728) in people who have opioid-induced constipation and associated chronic non-malignant pain. This... Read more »
7 Things You Didn't Know About Your Pain Medication
What's in your medication? Many pain medications contain both an opioid (like hydrocodone or oxycodone) and acetaminophen (commonly known by its brand name Tylenol). The purpose of combining acetaminophen with an opioid analgesic is to increase...
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
